Author: FWA

Summary: In older patients with type 2 diabetes mellitus (T2DM), periodontal health interventions based on the Pender Health Promotion Model significantly improved periodontal health outcomes and quality of life compared to standard care without a specific periodontal health intervention, though it was associated with no significant reported side effects. PICO Description Population Older patients with type 2 diabetes mellitus (T2DM) experiencing periodontal issues. Intervention Periodontal health interventions based on the Pender Health Promotion Model. Comparison Standard care without targeted periodontal health intervention. Outcome Significant improvements in periodontal health indices and enhanced overall quality of life were observed. No adverse effects…

Read More

Summary: In patients with type 2 diabetes mellitus and periodontitis enrolled in a randomized clinical trial, periodontal therapy including scaling and root planing with machine learning analysis of baseline factors demonstrated significant improvement in clinical parameters (probing depth, clinical attachment level, plaque index) and HbA1c at 6 months compared to patients stratified by baseline characteristics to identify predictors of treatment success, with nine baseline factors identified as important for predicting treatment response including initial periodontal severity and glycemic control. PICO Description Population Patients with type 2 diabetes mellitus and periodontitis enrolled in a randomized clinical trial of periodontal therapy. Intervention…

Read More

Summary: In patients after acute myocardial infarction, dapagliflozin treatment significantly reduced new onset type 2 diabetes mellitus (T2DM) and improved heart failure symptom burden compared to placebo, though it was associated with no significant adverse effects. PICO Description Population Patients following acute myocardial infarction, including those with normoglycemia or prediabetes. Intervention Dapagliflozin treatment (dose: 10 mg daily) as a cardiometabolic therapy. Comparison Placebo treatment in patients with normoglycemia or prediabetes. Outcome Dapagliflozin significantly reduced new-onset T2DM following myocardial infarction and improved heart failure symptom burden, particularly in patients with prediabetes. The benefits were observed regardless of baseline hemoglobin A1c or…

Read More

Summary: In women with gestational diabetes mellitus (GDM), Cognitive Behavioral Therapy (CBT)-based digital dietary intervention significantly improved postprandial blood glucose (PBG) levels and pregnancy outcomes compared to standard dietary intervention, though it was associated with no reports of notable adverse effects. PICO Description Population Pregnant women diagnosed with gestational diabetes mellitus (GDM) requiring dietary interventions for glycemic control. Intervention Cognitive Behavioral Therapy (CBT)-based digital dietary intervention aimed at improving dietary habits and glycemic control. Comparison Standard dietary intervention provided as part of typical gestational diabetes management. Outcome The CBT-based intervention significantly improved postprandial blood glucose (PBG) levels and was associated…

Read More

Summary: In pregnant individuals with gestational diabetes mellitus (GDM), real-time continuous glucose monitoring (CGM) significantly increased the percentage of time in range (%TIR) compared to capillary blood glucose (CBG) monitoring, though it was associated with the need for further exploration of its impact on perinatal and neonatal outcomes. PICO Description Key Factor

Read More

Summary: In postmenopausal women with type 2 diabetes, home-based multi-task exercise training significantly improved executive function and the TNF/IL-10 ratio compared to no intervention, though it was associated with minimal adverse events related to physical strain. PICO Description Population Postmenopausal women aged 50-75 years with type 2 diabetes. Intervention A home-based, dual-task exercise training program combining physical and cognitive tasks. Comparison No intervention or usual care without structured exercise training. Outcome The exercise program resulted in significant improvements in executive function (using standardized cognitive tests) and the TNF/IL-10 cytokine ratio. Additionally, participants showed better physical performance measures and glycemic control,…

Read More

Summary: In patients with clinically significant macular edema (CSME) in type 2 diabetes mellitus, low-dose atorvastatin (10-20 mg) significantly improved functional and anatomical outcomes compared to high-dose atorvastatin, though it was associated with minimal side effects. PICO Description Population Patients with clinically significant macular edema (CSME) secondary to type 2 diabetes mellitus. Intervention Low-dose atorvastatin (10-20 mg) as adjunctive therapy to anti-VEGF treatment. Comparison High-dose atorvastatin (40-80 mg) used alongside anti-VEGF therapy. Outcome Low-dose atorvastatin significantly improved functional (e.g., visual acuity) and anatomical outcomes (e.g., retinal thickness) compared to high-dose treatment. Minimal side effects were reported for low-dose use. Source:…

Read More

Summary: In patients with diabetic macular edema (DME),intravitreal aflibercept combined with dexamethasone phosphate significantly improved short-term structural and functional outcomes compared to intravitreal aflibercept alone, though it was associated with steroid-related adverse effects such as increased intraocular pressure. PICO Description Population Adults with diabetic macular edema (DME) confirmed by optical coherence tomography and clinical evaluation. Intervention Intravitreal aflibercept administered in combination with dexamethasone sodium phosphate. Comparison Intravitreal aflibercept monotherapy alone. Outcome The combination treatment led to significant improvements in retinal thickness and visual acuity over the short term. However, it was associated with steroid-related adverse effects, including increased intraocular pressure,…

Read More

Summary: In adults with obesity or overweight without type 2 diabetes, tirzepatide treatment significantly improved β-cell function and insulin sensitivity compared to baseline, though it was associated with some gastrointestinal side effects, such as nausea and diarrhea. PICO Description Population Adults with obesity or overweight without type 2 diabetes, including individuals with prediabetes or normoglycemia. Intervention Treatment with tirzepatide, a dual GLP-1/GIP receptor agonist, administered subcutaneously once weekly. Comparison Baseline measures of β-cell function and insulin sensitivity, with weight reduction considered as a covariate. Outcome Tirzepatide treatment resulted in significant improvements in β-cell function and insulin sensitivity compared to baseline.…

Read More

Summary: In diabetic patients in Egypt, the Diabetes Conversation Map (TM) program significantly improved knowledge retention, self-management behaviors, and self-efficacy compared to standard care or alternative DSMES programs, though it was associated with no significant adverse effects. PICO Description Population Diabetic patients in Egypt facing health and economic challenges. Intervention Diabetes Conversation Map (TM) program as a DSMES tool. Comparison Standard care or other alternative DSMES programs for diabetes management. Outcome The Diabetes Conversation Map (TM) program resulted in significantly improved knowledge retention, enhanced self-management behaviors, and increased self-efficacy in managing diabetes, with no reported significant adverse effects. Source: Shaimaa…

Read More